Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1976 1
1977 4
1979 2
1980 2
1981 6
1982 3
1983 5
1984 4
1985 5
1986 9
1987 6
1988 2
1989 2
1990 8
1991 5
1992 5
1993 9
1994 5
1995 7
1996 1
1997 11
1998 10
1999 15
2000 6
2001 8
2002 13
2003 17
2004 17
2005 25
2006 25
2007 31
2008 35
2009 36
2010 21
2011 29
2012 33
2013 20
2014 24
2015 15
2016 11
2017 12
2018 7
2019 13
2020 3
2021 3
2022 8
2023 7
2024 6
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

499 results

Results by year

Filters applied: . Clear all
Page 1
Sentinel Lymph Node Biopsy vs No Axillary Surgery in Patients With Small Breast Cancer and Negative Results on Ultrasonography of Axillary Lymph Nodes: The SOUND Randomized Clinical Trial.
Gentilini OD, Botteri E, Sangalli C, Galimberti V, Porpiglia M, Agresti R, Luini A, Viale G, Cassano E, Peradze N, Toesca A, Massari G, Sacchini V, Munzone E, Leonardi MC, Cattadori F, Di Micco R, Esposito E, Sgarella A, Cattaneo S, Busani M, Dessena M, Bianchi A, Cretella E, Ripoll Orts F, Mueller M, Tinterri C, Chahuan Manzur BJ, Benedetto C, Veronesi P; SOUND Trial Group. Gentilini OD, et al. Among authors: luini a. JAMA Oncol. 2023 Nov 1;9(11):1557-1564. doi: 10.1001/jamaoncol.2023.3759. JAMA Oncol. 2023. PMID: 37733364 Free PMC article.
Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial.
Galimberti V, Cole BF, Viale G, Veronesi P, Vicini E, Intra M, Mazzarol G, Massarut S, Zgajnar J, Taffurelli M, Littlejohn D, Knauer M, Tondini C, Di Leo A, Colleoni M, Regan MM, Coates AS, Gelber RD, Goldhirsch A; International Breast Cancer Study Group Trial 23-01. Galimberti V, et al. Lancet Oncol. 2018 Oct;19(10):1385-1393. doi: 10.1016/S1470-2045(18)30380-2. Epub 2018 Sep 5. Lancet Oncol. 2018. PMID: 30196031 Clinical Trial.
Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial.
Galimberti V, Cole BF, Zurrida S, Viale G, Luini A, Veronesi P, Baratella P, Chifu C, Sargenti M, Intra M, Gentilini O, Mastropasqua MG, Mazzarol G, Massarut S, Garbay JR, Zgajnar J, Galatius H, Recalcati A, Littlejohn D, Bamert M, Colleoni M, Price KN, Regan MM, Goldhirsch A, Coates AS, Gelber RD, Veronesi U; International Breast Cancer Study Group Trial 23-01 investigators. Galimberti V, et al. Among authors: luini a. Lancet Oncol. 2013 Apr;14(4):297-305. doi: 10.1016/S1470-2045(13)70035-4. Epub 2013 Mar 11. Lancet Oncol. 2013. PMID: 23491275 Free PMC article. Clinical Trial.
Identification and characterization of a new potent inhibitor targeting CtBP1/BARS in melanoma cells.
Filograna A, De Tito S, Monte ML, Oliva R, Bruzzese F, Roca MS, Zannetti A, Greco A, Spano D, Ayala I, Liberti A, Petraccone L, Dathan N, Catara G, Schembri L, Colanzi A, Budillon A, Beccari AR, Del Vecchio P, Luini A, Corda D, Valente C. Filograna A, et al. Among authors: luini a. J Exp Clin Cancer Res. 2024 May 6;43(1):137. doi: 10.1186/s13046-024-03044-5. J Exp Clin Cancer Res. 2024. PMID: 38711119 Free PMC article.
Models for Golgi traffic: a critical assessment.
Glick BS, Luini A. Glick BS, et al. Among authors: luini a. Cold Spring Harb Perspect Biol. 2011 Nov 1;3(11):a005215. doi: 10.1101/cshperspect.a005215. Cold Spring Harb Perspect Biol. 2011. PMID: 21875986 Free PMC article. Review.
Prohibitin: A Novel Molecular Player in KDEL Receptor Signalling.
Giannotta M, Fragassi G, Tamburro A, Vanessa C, Luini A, Sallese M. Giannotta M, et al. Among authors: luini a. Biomed Res Int. 2015;2015:319454. doi: 10.1155/2015/319454. Epub 2015 May 10. Biomed Res Int. 2015. PMID: 26064897 Free PMC article.
Phosphatidic acid in membrane rearrangements.
Zhukovsky MA, Filograna A, Luini A, Corda D, Valente C. Zhukovsky MA, et al. Among authors: luini a. FEBS Lett. 2019 Sep;593(17):2428-2451. doi: 10.1002/1873-3468.13563. Epub 2019 Aug 31. FEBS Lett. 2019. PMID: 31365767 Free article. Review.
499 results